Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35831
NL-OMON35831
Completed
Phase 3

Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX) - Safety and Effectiveness during DEXmedetomidine sedation.

Academisch Medisch Centrum0 sites64 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
64
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age range \* 18 years
  • •ASA classification I \* III
  • •Patients, undergoing elective oesophagus intervention
  • •Written informed consent

Exclusion Criteria

  • •Age range \< 18 years
  • •ASA classification IV and V
  • •Allergic reaction to planned medication in the patients\* medical history
  • •Unregulated hypertension
  • •Hypovolemia or hypotension (SBP \<80 or MAP \<50\)
  • •Sever bradycardia (rate \< 50\) and / or related bradydysrhymias (e.g. advanced heart block)
  • •Impaired ventricular functions (EF \<30%)
  • •GFR less than 15ml/min or undergoing hemodialysis
  • •End stage liver disease
  • •Substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventions
ISRCTN68599804Academic Medical Centre (AMC) (Netherlands)64
Completed
Phase 4
A clinical study to find whether dexmedetomidine provides adequate comfort to patients during awake nasal fibreoptic intubatioHealth Condition 1: null- Scheduled for awake nasal fibreoptic intubation in view of assessed difficult airway
CTRI/2012/09/002948Kasturba Hospital KMC Manipal36
Not yet recruiting
Not Applicable
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgery
CTRI/2024/07/070582Dr Sridevi Mulimani
Completed
Not Applicable
To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTPHealth Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY
CTRI/2017/11/010353ALL INDIA INSTITUTE OF MEDICAL SCIENCES80
Active, not recruiting
Not Applicable
The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks (regional anesthesia) for shoulder surgeryThe goal of the present study is to investigate the safety and efficiacy of dexmedetomidine added toropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans.Provided the initial safety can be established, the trial will continue to evaluate secondary goalsincluding the duration of analgesia, onset of sensory and motor blockade, and opioid-inducedside effects. Tertiary outcomes will include activity, sleep, and subject satisfaction.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2011-002175-42-ATParacelsus Medizinische Universität - Universitätsklinik für Anästhesie